To strengthen its presence in cancer care solutions, Dr Devi Shetty, chairman, and executive director, Narayana Health and Kiran Mazumdar Shaw, executive chairperson, Biocon Limited and Biocon Biologics Limited inaugurated a new bone marrow transplant (BMT) unit at Mazumdar Shaw Medical Centre, Narayana Health City.
The event was attended by Dr Emmanuel Rupert, managing director and Group CEO, Narayana Health and Dr Sharat Damodar, chairman, Oncology Services and Clinical Director, MSMC, Narayana Health. With the launch, BMT Unit has strengthened its capacity to 34 beds by adding 10 new beds. 35 cancer survivors attended the event to raise awareness about cancer, the importance of early detection, and the latest treatment modalities.
The new unit aims to offer patients from Bengaluru, Karnataka and nearby areas easy access to international standard cancer care for bone marrow transplants. The unit will boost CAR-T Cell Therapy and Immunotherapy and has proficient medical staff including haemato-oncologists, BMT physicians and nursing staff.
BMT is an effective treatment modality for cancerous conditions such as acute and chronic myeloid and lymphoblastic leukemia, Hodgkin’s and non-hodgkin’s lymphoma, myeloproliferative neoplasms, primary myelofibrosis and multiple myeloma. It is also a preferred form of treatment for blood disorders such as aplastic anemia, immunodeficiency disorders, congenital storage disorders, congenital errors of metabolism and hemoglobinopathies such as thalassemia and sickle cell anemia.
The healthcare chain had successfully treated 2000 patients through bone marrow transplants in October 2022.
Founded by Dr Devi Shetty and headquartered in Bengaluru, Narayana Health group is one of the largest healthcare providers in India in terms of operational bed count.
